Cite
HARVARD Citation
Blum, K. et al. (2019). Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance). Cancer. 125 (19), pp. 3378-3389. [Online].